Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Mounjaro and Wegovy are both weight loss injections that can help you lose and maintain a healthy weight. Both are popular treatments, although there are similarities and differences between the two, such as their active ingredients, dosage schedules, and effectiveness. Here we compare Mounjaro vs Wegovy for weight loss, so you can decide which treatment is right for you.
Mounjaro and Wegovy are both weight loss injections that belong to a group of medications called glucagon-like peptide 1 (GLP-1) receptor agonists. They both work by mimicking GLP-1, a naturally occurring hormone that manages hunger levels. This:
What are the differences between Mounjaro and Wegovy?
Mounjaro contains tirzepatide, a dual agonist. As well as being a GLP-1 receptor agonist, it also mimics a second hormone called glucose-dependent insulinotropic peptide (GIP). This is thought to further enhance the effects of GLP-1. Wegovy contains semaglutide, which is a GLP-1 receptor agonist.
Although the active ingredient is different, both Mounjaro and Wegovy are appetite suppressants that send signals to your brain that you’re full and delay the emptying of your stomach. They can also help to regulate blood sugar levels, which may further help with cravings and energy levels.
Weight loss pens are a prescription-only weight loss medication for people who are overweight. The weight loss injection pens are very simple to use. It’s a virtually pain-free daily injection. Taking the medication as per the guidelines by our doctor will restrict your appetite, making you feel full after smaller meal sizes and therefore you should lose a significant amount of weight.
The pen can be injected any time of the day, with or without food. Weight loss pens has shown to reduce your appetite and cravings for food, make you feel fuller quicker, fuller for longer and ultimately help you lose weight.
Wegovy & Mounjaro are licensed for weight loss in conjunction with a low-calorie diet and exercise, so its optimal efficacy is when they are followed correctly. It is important to follow the dose escalation guidelines which we send to you after you place your consultation and order.
Includes consultation with our Doctor, your prescription fee and one - one demo
Wegovy Monthly pens
0.25mg, 0.5mg & 1mg £220
Wegovy Monthly pens
1.7mg £275
Wegovy Monthly pens
2.4mg £350
Mounjaro Monthly pens
2.5mg £225
Mounjaro 5mg Monthly pens
5.0mg £225
Mounjaro 5mg Monthly pens
7.5mg £237
Mounjaro 5mg Monthly pens
10.0mg £237
Mounjaro 5mg Monthly pens
12.0mg £300
Mounjaro 5mg Monthly pens
15.0mg £300
04 Feb 2025
Dear Cambridge Aesthetics clients, i would like to keep you up to date with new rules and legislation that came into play with immediate effect from today. We are NOT an online pharmacy and the way we operate should not change moving forward as not only do you have a consultation with our Doctor be we also see you face to face on your collection demo.However having said that we are looking into if we need to change our phone consultations to zoom calls. Currently we operate within the parameters and the new rules also. But i know a lot of our clients have friends who purchase online to save money and felt this is a great read and would be beneficial for them to read.
Online pharmacies “cannot” prescribe based on online questionnaires alone and must “independently verify” patients’ weight and height before prescribing weight loss drugs, the General Pharmaceutical Council (GPhC) has announced.
“Not meeting our standards could result in us taking enforcement action"
“All online pharmacies in Great Britain will have to strengthen safeguards” thanks to GPhC guidance updated “in response to concerns identified relating to unsafe prescribing and supply of medicines online”, the regulator today (February 4) revealed.
The new guidance, which sets out how pharmacies can meet the regulator’s legal requirements, comes after its consultation launched in Septembergarnered concerns that proposed changes risked “watering down” online pharmacy rules.
Now, the GPhC has said that it has taken feedback on board to further strengthen the guidance, which “emphasises that for high-risk medicines, [a] prescriber cannot base prescribing decisions on the information provided in an online questionnaire alone”.
Online patient forms must be ‘supplemented’
“Instead, the prescriber has to independently verify the information the person provides,” it said. This will now be completed when you come to collect your medicine or via zoom call.
Information can be verified “either through timely two-way communication with the person, accessing the person’s clinical records, or contacting the person’s GP, their regular prescriber or a third-party provider”
It added that if the online prescriber “cannot independently verify” the information, the patient “should be directed to an appropriate care provider so that they can be appropriately assessed…
Weight loss medicines have also “been added to the list of high-risk medicines requiring extra safeguards before being prescribed”, the GPhC announced.
The new guidance said that “when supplying medicines used for weight management, the prescriber [should] independently [verify] the person’s weight, height and/or body mass index”.
“The guidance is coming into effect immediately,” Edwards told C+D.
“Online pharmacy owners and superintendent pharmacists are expected to review the updated guidance and make any changes needed to their online pharmacy’s operations, processes and digital platforms at the earliest opportunity,” she said.